annb0t
Top 20
AUCKLAND, New Zealand, Nov. 29, 2022 /PRNewswire/ -- Today New Zealand based soft-tissue regeneration company Aroa Biosurgery (AROA, the Company) is pleased to announce financial results for H1 FY23. Â With fewer COVID-19 related disruptions, the Company has entered FY23 with momentum and delivered strong financial results. Aroa Biosurgery
Aroa reports a strong cash balance of NZ$50.1 million as at 30 September 2022 and is debt free.
Upgraded guidance of NZ$62-64 million.[1] , previously adv...
>>> Read more: AROA BIOSURGERY ANNOUNCES HALF YEAR RESULTS
Aroa reports a strong cash balance of NZ$50.1 million as at 30 September 2022 and is debt free.
Upgraded guidance of NZ$62-64 million.[1] , previously adv...
>>> Read more: AROA BIOSURGERY ANNOUNCES HALF YEAR RESULTS
